Results 21 to 30 of about 101,543 (348)
Automated Compounding of Intravenous Therapy in European Countries: A Review in 2019
Pharmaceutical Technology in Hospital Pharmacy, 2019 Automated compounding systems appeared on the market during these last 15 years as an alternative for manual compounding of intravenous (IVD) drugs. A literature review was conducted on reconstitution of IVD. The following methods were identified: manual,
Soumoy Laura, Hecq Jean-Daniel
doaj +1 more source
Advances in Materials Science and Engineering, 2020 In order to improve the safety, operability, and cleanability of the dust suppressant, this paper uses the surfactant monomers selected in the previous experiment as the main material formula and adds the inorganic salt as the synergist to prepare the ...
Jian He +6 more
doaj +1 more source
Frontiers in Endocrinology, 2022 Colorful traits (i.e., ornaments) that signal quality have well-established relationships with individual condition and physiology. Furthermore, ornaments expressed in females may have indirect fitness effects in offspring via the prenatal physiology ...
Braulio A. Assis +6 more
doaj +1 more source
Reducing Sensitivity Analysis Time-Cost of Compound Model [PDF]
IEEE Transactions on Magnetics, 2004 This paper deals with the sensitivity analysis of compound models in the case of gradient based optimization. Multidisciplinary optimization (MDO) may use time-consuming analysis such as the finite-element method (FEM) resolution, their sensitivity analysis must then be managed efficiently in order to limit their evaluations.
B. Delinchant, F. Wurtz, E. Atienza
openaire +1 more source
An engineering approach to business model experimentation – an online investment research startup case study [PDF]
, 2010 Every organization needs a viable business model. Strikingly, most of current literature is focused on business model design, whereas there is almost no attention for business model validation and implementation and related business model experimentation.
Boersma, Durk, Kijl, Björn
core +3 more sources
Pharmaceutical compounding of orphan active ingredients in Belgium : how community and hospital pharmacists can address the needs of patients with rare diseases [PDF]
, 2019 Background: Pharmaceutical compounding of orphan active ingredients can offer cost-effective treatment to patients when no other drug product is available for a rare disease or during periods of drug product shortages.
Boussery, Koen +7 more
core +2 more sources
A Low-Cost MEMS Missile-Borne Compound Rotation Modulation Scheme
Sensors, 2021 Rotation modulation (RM) has been widely used in navigation systems to significantly improve the navigation accuracy of inertial navigation systems (INSs). However, the traditional single-axis rotation modulation cannot achieve the modulation of all the constant errors in the three directions; thus, it is not suitable for application in highly dynamic ...
Xiaoqiao Yuan +6 more
openaire +3 more sources
Green Finance, 2023 This article proposes theoretical and analytical foundations for the economic assessment of the results of green investments in terms of promoting territorial sustainability. The green investments are presented as resources aimed at reducing the economic
Vladimir Kurdyukov, Alla Ovcharenko
doaj +1 more source
Low cost whole-organism screening of compounds for anthelmintic activity [PDF]
International Journal for Parasitology, 2015 Due to major problems with drug resistance in parasitic nematodes of animals, there is a substantial need and excellent opportunities to develop new anthelmintics via genomic-guided and/or repurposing approaches. In the present study, we established a practical and cost-effective whole-organism assay for the in vitro-screening of compounds for activity
Preston, Sarah +12 more
openaire +3 more sources
Automated Generation of hiPSC-Derived Hepatic Progeny by Cost-Efficient Compounds
Stem Cells, 2023 Abstract Human pluripotent stem cell (hPSC)-derived hepatocyte-like cells (HLCs) hold great promise for liver disease modeling, drug discovery, and drug toxicity screens. Yet, several hurdles still need to be overcome, including among others decrease in the cost of goods to generate HLCs and automation of the differentiation process.
Vanmarcke, Gert +13 more
openaire +4 more sources